Financial Gravity Asset Management, Inc. Enanta Pharmaceuticals Inc Transaction History

Financial Gravity Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $0 - $0	0 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	SELL	$46.37 - $57.58 $278 - $345	-6 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$40.22 - $62.0 $603 - $930	-15 Reduced 71.43%	6 $0
Q4 2019 Feb 28, 2020	SELL	$57.95 - $66.61 $173 - $199	-3 Reduced 12.5%	21 $62,000
Q3 2019 Oct 15, 2019	SELL	$60.08 - $88.17 $360 - $529	-6 Reduced 20.0%	24 $1,000
Q2 2019 Jul 26, 2019	SELL	$81.3 - $97.35 $39,267 - $47,020	-483 Reduced 94.15%	30 $3,000
Q1 2019 Apr 19, 2019	BUY	$69.08 - $105.66 $31,224 - $47,758	452 Added 740.98%	513 $49,000
Q3 2018 Oct 31, 2018	BUY	$85.46 - $126.37 $1,110 - $1,642	13 Added 27.08%	61 $4,000
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $6,875 - $10,122	-84 Reduced 63.64%	48 $5,000
Q1 2018 May 23, 2018	BUY	$57.91 - $92.15 $7,644 - $12,163	132 New	132 $13,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.